Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Diet and Metformin in Glioblastoma
NCT04691960Phase 2Active, not recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Aug 2016
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in glioma, sponsored by Weill Cornell Medicine. Started Aug 2016; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
glioma
Beyond the preview
Go deeper on NCT04691960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04691960.